Responses
Regular and Young Investigator Award Abstracts
Tumor and Stromal Cell Biology
922 A novel autotaxin inhibitor, IOA-289, modulates tumor, immune and stromal cell function and has monotherapy activity in fibrotic cancer models
Compose a Response to This Article
Other responses
No responses have been published for this article.